By directing the delivery of the NMDA receptor antagonist MK-801 via GLP-1 pathways, the researchers were able to influence neuroplasticity in the hypothalamus and brainstem
Preclinical work with GLP-1R/GIPR/GcgR triple agonists showed that a balanced triple agonist produced greater body-weight loss than semaglutide, tirzepatide, and dual co-agonists in diet-induced obese mice, reducing weight to near-lean levels at the highest doses
Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages
Give each new dose level at least 2 weeks before evaluating
Although the FAERS database aids in detecting rare adverse events via spontaneous reporting, its propensity to overestimate unexpected adverse events linked to new therapies makes it inappropriate for comparative analysis of adverse event frequencies among pharmaceuticals
The difference comes from how many hormone pathways each medication targets